This study found that among ambulatory, HIV positive outpatients with severe baseline immunosuppression (CD4 < 100 cells/μL) in the first year of ART, nearly one-third had a new TB diagnosis (prevalent or incident TB) and one-quarter had at least one adverse outcome, including need for hospitalization, LTFU, or death. This evidence concerns the gene CD4 and tuberculosis.